1. Home
  2. XPO vs DGX Comparison

XPO vs DGX Comparison

Compare XPO & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XPO Inc.

XPO

XPO Inc.

HOLD

Current Price

$228.66

Market Cap

21.3B

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$196.01

Market Cap

23.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPO
DGX
Founded
2000
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.3B
23.1B
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
XPO
DGX
Price
$228.66
$196.01
Analyst Decision
Buy
Buy
Analyst Count
18
12
Target Price
$177.35
$208.92
AVG Volume (30 Days)
1.3M
672.8K
Earning Date
04-30-2026
04-21-2026
Dividend Yield
N/A
1.76%
EPS Growth
N/A
13.78
EPS
2.64
8.75
Revenue
$7,744,000,000.00
$11,035,000,000.00
Revenue This Year
$5.79
$7.53
Revenue Next Year
$6.39
$3.77
P/E Ratio
$85.26
$22.24
Revenue Growth
0.34
11.78
52 Week Low
$93.48
$164.65
52 Week High
$231.46
$213.50

Technical Indicators

Market Signals
Indicator
XPO
DGX
Relative Strength Index (RSI) 72.49 49.07
Support Level $123.93 $191.75
Resistance Level N/A $200.49
Average True Range (ATR) 7.43 4.38
MACD 2.46 -0.13
Stochastic Oscillator 92.34 53.46

Price Performance

Historical Comparison
XPO
DGX

About XPO XPO Inc.

Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. We estimate LTL shipping makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: